By Devika Patel
Knoxville, Tenn., Feb. 1 - VentriPoint Diagnostics Ltd. said it plans to conduct a C$2 million private placement of stock.
The company will sell 20 million common shares at C$0.10 per share.
Proceeds will be used for product and service commercialization of the VentriPoint Medical System, expansion of applications to include additional diagnoses and heart diseases and for general working capital.
Based in Calgary, Alta., VentriPoint Diagnostics is the holding company for Seattle-based clinical diagnostic company VentriPoint, Inc.
| Issuer: | VentriPoint Diagnostics Ltd.
|
| Issue: | Common shares
|
| Amount: | C$2 million
|
| Shares: | 20 million
|
| Price: | C$0.10
|
| Warrants: | No
|
| Pricing date: | Feb. 1
|
| Stock symbol: | TSX Venture: VPT
|
| Stock price: | C$0.115 at close Jan. 29
|
| Market capitalization: | C$4.19 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
